3 news items
Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE
TAK
27 Mar 24
tract3. While inflammation is the body's natural reaction to irritation or injury, in patients with IBD, it is thought that the body's own
Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia
TAK
13 Mar 24
cells, natural killer cells) resulting in their depletion.
The TAK-079-1004 trial
Takeda and Biological E. Limited Collaborate to Accelerate Access to Dengue Vaccine in Endemic Areas
TAK
26 Feb 24
.
6 Guzman MG, et al. Dengue: a continuing global threat. Nature
- Prev
- 1
- Next